Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. Show More...

  • Website https://www.insmed.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 69.73 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -0.49 -2.95 -1.56 -1.6 -1.84 -2.02 -2.85 -2.89 -4.22 -3.01 -2.79
    Dividends USD
    Payout Ratio % *
    Shares Mil 13.0 23.0 27.0 35.0 43.0 59.0 62.0 67.0 77.0 85.0 88.0
    Book Value Per Share * USD 12.26 5.73 3.83 4.01 4.0 5.48 3.51 5.5 3.77 3.39 2.05
    Free Cash Flow Per Share * USD -0.58 -1.63 -1.18 -1.28 -1.72 -1.63 -1.94 -2.72 -3.24 -3.81
    Return on Assets % -3.98 -40.96 -28.2 -33.98 -38.86 -40.24 -59.3 -55.04 -60.81 -37.77 -38.75
    Financial Leverage (Average) 1.02 1.04 1.27 1.23 1.24 1.14 1.54 1.28 2.9 2.84 3.27
    Return on Equity % -4.07 -42.21 -32.43 -42.45 -48.04 -47.47 -75.62 -74.74 -113.92 -108.24 -140.55
    Return on Invested Capital % -4.02 -42.03 -29.46 -35.42 -41.56 -41.87 -63.64 -59.67 -63.48 -38.14 -40.65
    Interest Coverage -57.31 -53.23 -22.75 -36.09 -40.59 -49.36 -31.56 -11.72 -8.64 -8.11
    Current Ratio 32.58 17.29 5.94 7.06 8.39 12.94 6.02 8.72 6.51 6.51 6.89
    Quick Ratio 32.5 17.21 5.9 6.92 8.11 12.71 5.81 8.54 6.28 5.94 6.24
    Debt/Equity 0.010 0.13 0.11 0.13 0.07 0.35 0.15 1.52 1.47 1.87